CODX vs XRAY · rev $3.9M vs rev $3.68B
Co-Diagnostics, Inc. Common Stock (CODX) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported XRAY revenue for 2025-12-31 was $3.68B. Net income was -$598.0M. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. XRAY currently screens at market cap $2.01B.
CODX currently screens at market cap $31.4M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the CODX and XRAY stock pages for the full models.
Not investment advice.